Generate Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8M Buy
49,548
+36,292
+274% +$17.4M 1.02% 22
2026
Q1
$6.52M Sell
13,256
-22,390
-63% -$12.2M 0.32% 51
2025
Q4
$20.7M Buy
35,646
+20,243
+131% +$11.4M 0.94% 30
2025
Q3
$7.47M Buy
+15,403
New +$7.17M 0.38% 71
2025
Q2
Sell
-17,131
Closed -$8.52M 101
2025
Q1
$8.52M Buy
17,131
+1,157
+7% +$627K 0.6% 49
2024
Q4
$8.31M Sell
15,974
-8,191
-34% -$4.5M 0.58% 60
2024
Q3
$14.9M Buy
24,165
+4,866
+25% +$2.88M 1% 36
2024
Q2
$10.7M Sell
19,299
-3,045
-14% -$1.74M 0.63% 48
2024
Q1
$13M Sell
22,344
-18,287
-45% -$10.3M 0.94% 32
2023
Q4
$21.6M Buy
+40,631
New +$19.7M 1.86% 16

Other funds holding TMO

Generate Investment Management's TMO Position: Q2 2026 in Review

Generate Investment Management increased its Thermo Fisher Scientific (TMO) stake by 274% in Q2 2026, buying an estimated $17.4M and bringing the position to 49,548 shares worth $24.8M. The position accounts for 1.02% of the portfolio, ranked #22.

Generate Investment Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Generate Investment Management held 49,548 shares of Thermo Fisher Scientific worth $24.8M as of Q2 2026.
  • Generate Investment Management bought 36,292 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.4M.
  • Thermo Fisher Scientific made up 1.02% of Generate Investment Management's portfolio in Q2 2026, its #22 holding.
  • Generate Investment Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.